Metastatic Urothelial Cancer Recruiting Phase 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0066157 (Metastatic Urothelial Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03547973Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadTreatment